Preparation, characterization and pulmonary pharmacokinetics of a new inhalable zanamivir dry powder

References

• Asada M, Takahashi H, Okamoto H, et al. (2004). Theophlline particle design using chitosan by the spray drying. Int J Pharm 270:167–74
   PubMed Web of Science ®Google Scholar
• Batycky RP, Lipp MM, Niven RW. (2004). Use of simple amino acids to form porous particles. US patent 7:252,840
   Google Scholar
• Bevard V, Lesniewska E, Andres C, et al. (2002). Dry powder inhaler: influence of humidity on topology and adhesion studied by AFM. Int J Pharm 232:213–24
   PubMed Web of Science ®Google Scholar
• Bivas-Benita M, Zwier R, Junginger HE, Borchard G. (2005). Non-invasive pulmonary aerosol delivery in mice by the endotracheal route. Eur J Pharm Biopharm 61:214–18
   PubMed Web of Science ®Google Scholar
• Bosquillon C, Lombry C, Préat V, Vanbever R. (2001). Influence of formulation excipients and physical characteristics of inhalation dry powders on their aerosolisation performance. J Control Release 70:329–39
   PubMed Web of Science ®Google Scholar
• Chan HK, Clark AR, Feeley JC, et al. (2004). Physical stability of salmone calcitonin spray-dried powders for inhalation. J Pharm Sci 93:792–804
   PubMed Web of Science ®Google Scholar
• Chougule MB, Padhi BK, Jinturkar KA, Misra A. (2007). Development of dry powder inhalers. Recent Pat Drug Deliv Formul 1:11–21
   PubMedGoogle Scholar
• Cline D, Dalby R. (2002). Predicting the quality of powders for inhalation from surface energy and area. Pharm Res 19:1274–7
   PubMed Web of Science ®Google Scholar
• Cook RO, Pannu RK, Kellaway IW. (2005). Novel sustained release microsphere for pulmonary drug delivery. J Control Release 104:79–90
   PubMed Web of Science ®Google Scholar
• Cox RJ, Mykkeltvedt E, Sjursen H, Haaheim LR. (2001). The effect of Zanamivir treatment on the early immune response to influenza vaccination. Vaccine 19:4743–9
   PubMed Web of Science ®Google Scholar
• Donovan MJ, Gibbons A, Herpin MJ, et al. (2011). Novel dry powder inhaler particle-dispersion systems. Ther Deliv 2:1295–311
   PubMedGoogle Scholar
• Duret C, Wauthoz N, Merlos R, et al. (2012). In vitro and in vivo evaluation of a dry powder endotracheal insufflator device for use in dose-dependent preclinical studies in mice. Eur J Pharm Biopharm 81:627–34
   PubMed Web of Science ®Google Scholar
• Gliniski J, Chavepeyer G, Platten JK. (2000). Surface properties of aqueous solutions of l-leucine. Biophys Chem 84:99–103
   PubMed Web of Science ®Google Scholar
• Hickey AJ, Mansour HM, Martin JT, et al. (2007). Physical characterization of component particles included in dry powder inhalers. I. Strategy review and static characteristics. J Pharm Sci 96:1282–301
   PubMed Web of Science ®Google Scholar
• Khodadoust S, Hadjmohammadi M. (2011). Determination of N-methylcarbamateinsecticides in water samples using dispersive liquid–liquid microextraction and HPLC with the aid of experimental design and desirability function. Anal Chim Acta 699:113–19
   PubMed Web of Science ®Google Scholar
• Lechuga-Ballesteros D, Charan C, Stults CLM, et al. (2008). Trileucine improves aerosol performance and stability of spray-dried powders for inhalation. J Pharm Sci 97:287–302
   PubMed Web of Science ®Google Scholar
• Lee HK, Kwon JH, Park SH, Kim CW. (2006). Insulin microcrystals prepared by the seed zone method. J Cryst Growth 293:447–51
   Web of Science ®Google Scholar
• Lucas P, Anderson K, Potter UJ, Staniforth JN. (1999). Enhancement of small particle size dry powder aerosol formulations using an ultra low density additive. Pharm Res 16:1643–7
   PubMed Web of Science ®Google Scholar
• Maa YF, Ameri M, Shu C, et al. (2004). Influenza vaccine powder formulation development: spray-freeze-drying and stability evaluation. J Pharm Sci 93:1912–23
   PubMed Web of Science ®Google Scholar
• Najafabadi AR, Gilani K, Barghi M, Rafiee-Tehrani M. (2004). The effect of vehicle on physical properties and aerosolisation behaviour of disodium cromoglycate microparticles spray dried alone or with l-leucine. Int J Pharm 285:97–108
   PubMed Web of Science ®Google Scholar
• Ogain ON, Li J, Taiber L, et al. (2011). Particle engineering of materials for oral inhalation by dry powder inhalers. I. Particles of sugar excipients (trehalose and raffinose) for protein delivery. Int J Pharm 405:23–35
   PubMed Web of Science ®Google Scholar
• Padhi B, Chougule M, Misra A. (2006). Optimization of formulation and characterization of large respirable powders containing high therapeutic payload. Pharm Dev Technol 11:465–75
   PubMed Web of Science ®Google Scholar
• Peskin RL, Raco RJ. (1963). Ultrasonic atomization of liquids. J Acoust Soc Am 35:1378–81
   Web of Science ®Google Scholar
• Raula J, Kurkela JA, Brown DP, Kauppinen EI. (2007). Study of the dispersion behavior of l-leucine containing microparticles synthesized with an aerosol flow reactor method. Powder Technol 177:125–32
   Web of Science ®Google Scholar
• Raula J, Laehde A, Kauppinen EI. (2008). A novel gas phase method for the combined synthesis and coating of pharmaceutical particles. Pharm Res 25:242–5
   PubMed Web of Science ®Google Scholar
• Raula J, Thielmann F, Naderi M, et al. (2010). Investigations on particle surface characteristics vs. dispersion behaviour of l-leucine coated carrier-free inhalable powders. Int J Pharm 385:79–85
   PubMed Web of Science ®Google Scholar
• Schule S, Schulz-Fademrecht T, Garidel P, et al. (2008). Stabilization of IgG1 in spray-dried powders for inhalation. Eur J Pharm Biopharm 69:793–807
   PubMed Web of Science ®Google Scholar
• Seville PC, Learoyd TP, Li HY, et al. (2007). Amino acid modified spray dried powders with enhanced aerosolisation properties for pulmonary drug delivery. Powder Technol 178:40–50
   Web of Science ®Google Scholar
• Stahl K, Claesson M, Lilliehorn P, et al. (2002). The effect of process variables on the degradation and physical properties of spray dried insulin intended for inhalation. Int J Pharm 233:227–37
   PubMed Web of Science ®Google Scholar
• Steckel H, Brandes HG. (2004). A novel spray-drying technique to produce low density particles for pulmonary delivery. Int J Pharm 278:187–95
   PubMed Web of Science ®Google Scholar
• Steckel H, Bolzen N. (2004). Alternative sugars as potential carriers for dry powder inhalations. Int J Pharm 270:297–306
   PubMed Web of Science ®Google Scholar
• Yang Y, Yang ZW, Ren YF, et al. (2014). Effects of formulation and operating variables on Zanamivir dry powder inhalation characteristics and aerosolization performance. Drug Deliv 21:480–6
   PubMed Web of Science ®Google Scholar
• Yu Z, Xiaoli W, Xia L, et al. (2010). High azithromycin loading powders for inhalation and their in vivo evaluation in rats. Int J Pharm 395:205–14
   PubMed Web of Science ®Google Scholar